Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
Amgen Inc
(NASDAQ:AMGN)
243.87
Delayed Data
As of
4:00pm ET
-1.30
/
-0.53%
Today’s Change
214.39
Today
|||
52-Week Range
296.67
-7.15%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest AMGN News
|
Press Releases
Will These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb?
Feb 04 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Q4 Earnings Top, 2023 View Disappoints, Stock Down
Jan 31 / Zacks.com - Paid Partner Content
Capital Wealth Planning, LLC Buys 2, Sells 3 in 4th Quarter
Feb 03 / GuruFocus News - Paid Partner Content
Is a Surprise Coming for Amgen (AMGN) This Earnings Season?
Jan 30 / Zacks.com - Paid Partner Content
Top 5 4th Quarter Trades of First Dallas Securities Inc.
Feb 03 / GuruFocus News - Paid Partner Content
Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know
Jan 26 / Zacks.com - Paid Partner Content
Why Amgen Stock Wilted on Wednesday
Feb 01 / MotleyFool.com - Paid Partner Content
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Jan 26 / Zacks.com - Paid Partner Content
Amgen (AMGN) Beats on Q4 Earnings, 2023 Sales View Disappoints
Feb 01 / Zacks.com - Paid Partner Content
2 Top Biotech Stocks to Buy for the Long Haul
Jan 26 / MotleyFool.com - Paid Partner Content
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
Feb 01 / Zacks.com - Paid Partner Content
Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline
Jan 25 / Zacks.com - Paid Partner Content
Compared to Estimates, Amgen (AMGN) Q4 Earnings: A Look at Key Metrics
Feb 01 / Zacks.com - Paid Partner Content
Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?
Jan 25 / Zacks.com - Paid Partner Content
Amgen (AMGN) Surpasses Q4 Earnings and Revenue Estimates
Jan 31 / Zacks.com - Paid Partner Content